Performance Enhancing Drug Testing for Navy Drug Demand Reduction Program (DDRP)
SAM.GOV Due: May 6, 2025 at 04:00 PM UTC
In-Active Sources Sought Source Url

Summary

The opportunity for Performance Enhancing Drug Testing under the Navy Drug Demand Reduction Program (DDRP) involves providing comprehensive testing services for anabolic steroids and other performance-enhancing substances as outlined by various regulatory bodies, including the Department of Defense and the World Anti-Doping Agency. Contractors will be responsible for analyzing human urine specimens and must adhere to strict guidelines and procedures set forth by the DOD and WADA. This opportunity is suitable for businesses with expertise in laboratory testing, particularly those familiar with drug testing protocols and compliance with military standards.
Description

The contractor shall provide to the Government all labor, materials, facilities, and equipment necessary to analyze the human urine specimens for anabolic steroids as defined in the Designer Anabolic Steroid Control Act of 2014 including subsequent amendments and all performance enhancing substan

Entities
DOD
Department of Defense
DOTN
Department of the Navy
NAICS
541380
Set Aside
None
Place of Performance
Maryland 21702
Point of Contact
Full Name Email Phone Type
Austin Waller - Contracting Specialist [email protected] primary
Attachments
  • PWS+-+DDRP+PED+Testing.docx
  • Essential+Characteristics+PED+testing_NSW.docx